USSEC Develops Approach to Dispel Biotech Myths in China
- General News
In response to the bogging down of the biotech approval process in China and erroneous reports in that country’s media, USSEC has developed numerous tactics to help combat some of the myths surrounding biotechnology. Because China is U.S soy’s top export market purchasing just over 60 percent of U.S. soy, USSEC is concerned about the misinformation and has cultivated an approach to educate Chinese buyers and consumers about biotech.
USSEC is currently using a three-prong plan as the organization works on improving the biotech approval situation in China on behalf of the U.S. soy industry:
Another tactic employed by USSEC includes a brochure, “Dispelling the Myths,” which is being produced in both English and Chinese. This brochure will be disseminated to customers and will also be posted on the biotechnology area of the USSEC website along with a white paper of the same title.
Dispelling the Myths can be viewed here.